Literature DB >> 7498318

Nitric oxide synthase activity is elevated in inflammatory lung disease in humans.

M Belvisi1, P J Barnes, S Larkin, M Yacoub, S Tadjkarimi, T J Williams, J A Mitchell.   

Abstract

We have characterised nitric oxide (NO) synthase activity in lung samples from patients with inflammatory lung disease compared to that in normal donor lung. NO synthase activity was measured by the ability of tissue homogenates to convert L-arginine to L-citrulline. Higher levels of NO synthase activity were found in samples from patients with inflammatory lung disease (mild asthma, cystic fibrosis, obliterative bronchiolitis after lung transplantation) compared to samples from healthy donors. NO synthase activity in all samples was mainly dependent on the presence of extracellular Ca2+. The increased NO synthase activity in diseased-lung samples suggests a modulatory role for nitric oxide in lung inflammation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7498318     DOI: 10.1016/0014-2999(95)00421-g

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

Review 1.  Exhaled nitric oxide: a new lung function test.

Authors:  P J Barnes; S A Kharitonov
Journal:  Thorax       Date:  1996-03       Impact factor: 9.139

2.  Reduced upper airway nitric oxide in cystic fibrosis.

Authors:  I M Balfour-Lynn; A Laverty; R Dinwiddie
Journal:  Arch Dis Child       Date:  1996-10       Impact factor: 3.791

3.  Nitric oxide metabolites in cystic fibrosis lung disease.

Authors:  H Grasemann; I Ioannidis; R P Tomkiewicz; H de Groot; B K Rubin; F Ratjen
Journal:  Arch Dis Child       Date:  1998-01       Impact factor: 3.791

4.  Collagen deposition in a non-fibrotic lung granuloma model after nitric oxide inhibition.

Authors:  C M Hogaboam; C S Gallinat; C Bone-Larson; S W Chensue; N W Lukacs; R M Strieter; S L Kunkel
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

Review 5.  Respiratory syncytial virus infection: mechanisms of redox control and novel therapeutic opportunities.

Authors:  Roberto P Garofalo; Deepthi Kolli; Antonella Casola
Journal:  Antioxid Redox Signal       Date:  2012-09-07       Impact factor: 8.401

6.  Measurement of exhaled alveolar nitrogen oxide in patients with lung cancer: a friend from the past still precious today.

Authors:  Anastasios Kallianos; Sotirios Tsimpoukis; Paul Zarogoulidis; Kaid Darwiche; Andriani Charpidou; Ilias Tsioulis; Georgia Trakada; Konstantinos Porpodis; Dionysios Spyratos; Athanasios Panoutsopoulos; Lemonia Veletza; Konstantinos Kostopoulos; Charalampos Kostopoulos; Ilias Karapantzos; Kosmas Tsakiridis; Wolfgang Hohenforst-Schmidt; Konstantinos Zarogoulidis; Aggeliki Rapti; Konstantinos Syrigos
Journal:  Onco Targets Ther       Date:  2013-05-31       Impact factor: 4.147

7.  Expression of inducible nitric oxide synthase in healthy pleura and in malignant mesothelioma.

Authors:  Y Soini; K Kahlos; A Puhakka; E Lakari; M Säily; P Pääkkö; V Kinnula
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

8.  Nitric oxide in asthma physiopathology.

Authors:  Carla M Prado; Mílton A Martins; Iolanda F L C Tibério
Journal:  ISRN Allergy       Date:  2011-04-19

9.  Approach to the Connection between Meconium Consistency and Adverse Neonatal Outcomes: A Retrospective Clinical Review and Prospective In Vitro Study.

Authors:  Hueng-Chuen Fan; Fung-Wei Chang; Ying-Ru Pan; Szu-I Yu; Kuang-Hsi Chang; Chuan-Mu Chen; Ching-Ann Liu
Journal:  Children (Basel)       Date:  2021-11-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.